| Financial Year |
March 31 2023 |
| Monetary Funds |
484,170,539.37 |
| Held-for-trading Financial Assets |
85,007,747.25 |
| Notes Receivable |
17,853,400.00 |
| Accounts Receivable |
215,814,122.12 |
| Advances to Suppliers |
69,903,591.53 |
| Other Receivables |
1,389,798,875.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,358,299,834.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
915,668,766.07 |
| Total Current Assets |
11,777,254,293.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,589,831,069.70 |
| Long-term Equity Investment |
132,215,488.21 |
| Investment Properties |
534,457,213.54 |
| Fixed Assetes |
1,951,478,997.49 |
| Under-construction Projects |
621,605,606.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
335,726,835.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,636,456.48 |
| Deferred Income Tax Assets |
68,112,315.01 |
| Other Non-Current Assets |
12,863,664.70 |
| Sub-Total of Non-Current Assets |
5,263,279,068.75 |
| Total Assets |
17,040,533,361.98 |
| Short-Term Loans |
10,019,589.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,476,844,199.75 |
| Accounts Received In Advance |
807,168.92 |
| Employee Compensation Payable |
52,932,937.11 |
| Taxes Payable |
944,770,597.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,682,629,436.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,916,543,274.29 |
| Other Current Liabilities |
746,816,863.49 |
| Sub-Total of Current Liabilities |
14,052,655,978.01 |
| Long-term Loans |
826,981,990.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
168,538,815.30 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
235,059,933.16 |
| Sub-Total of Non-Current Liabilities |
1,281,405,289.58 |
| Total Liabilities |
15,334,061,267.59 |
| Paid-In Capital(Or Share Stock) |
2,466,988,633.00 |
| Capital Surplus |
57,995,594.59 |
| Surplus Reserve |
660,848,024.79 |
| LESS:Treasury Stock |
39,995,078.00 |
| Undistributed Profits |
-1,428,258,304.20 |
| Minority Stockholder's Interest |
-25,328,466.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,731,800,560.85 |
| Owner's Equity（Stockholder's Equity） |
1,706,472,094.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,040,533,361.98 |
